StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) stock

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.96+4.67 (+9.88%)

Close on Nov 18, 2026Market cap $1.55BP/E –Yield –

GeneDx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for GeneDx

GeneDx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More GeneDx figures

See a number that looks wrong?